Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited

LALPATHLAB

株式のランク #4516
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
株価
$20.35
最終同期: 2026-10-19
時価総額
$3.40B
変化(1日)
-0.86%
変化(1年)
13.63%
国
IN
取引 Dr. Lal PathLabs Limited (LALPATHLAB)

カテゴリー

Healthcare
Dr. Lal PathLabs Limited(LALPATHLAB)の配当利回りの履歴
Dr. Lal PathLabs Limited(銘柄コード: LALPATHLAB)の配当利回り(TTM)は2024-03-31時点で1.06%です。
過去5年間の平均配当利回り: 0.75%
Dr. Lal PathLabs Limited(LALPATHLAB)の2011から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 0.85% -18.27%
2025 1.04% -1.89%
2024 1.06% 55.88%
2023 0.68% 25.93%
2022 0.54% 20.00%
2021 0.45% -66.67%
2020 1.35% 110.94%
2019 0.64% 42.22%
2018 0.45% -6.25%
2017 0.48% 128.57%
2016 0.21% -8.70%
2015 0.23% 64.29%
2014 0.14% -36.36%
2013 0.22% 57.14%
2012 0.14% -36.36%
2011 0.22% 0.00%
類似企業または競合他社の配当利回り(TTM)